805 related articles for article (PubMed ID: 1707767)
1. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
2. Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor.
Yokoyama I; Waxman F
Mol Immunol; 1992; 29(7-8):935-47. PubMed ID: 1386141
[TBL] [Abstract][Full Text] [Related]
3. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
Yokoyama I; Waxman F
Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
Bindon CI; Hale G; Brüggemann M; Waldmann H
J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
[TBL] [Abstract][Full Text] [Related]
5. The IgG subclass pattern of complement activation depends on epitope density and antibody and complement concentration.
Garred P; Michaelsen TE; Aase A
Scand J Immunol; 1989 Sep; 30(3):379-82. PubMed ID: 2476845
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
Voice JK; Lachmann PJ
Eur J Immunol; 1997 Oct; 27(10):2514-23. PubMed ID: 9368604
[TBL] [Abstract][Full Text] [Related]
7. Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.
Rajnavölgyi E; Fazekas G; Lund J; Daeron M; Teillaud JL; Jefferis R; Fridman WH; Gergely J
Immunology; 1995 Apr; 84(4):645-52. PubMed ID: 7540592
[TBL] [Abstract][Full Text] [Related]
8. Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).
Boackle RJ; Nguyen QL; Leite RS; Yang X; Vesely J
Mol Immunol; 2006 Feb; 43(3):236-45. PubMed ID: 16199260
[TBL] [Abstract][Full Text] [Related]
9. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
Russell MW; Reinholdt J; Kilian M
Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
[TBL] [Abstract][Full Text] [Related]
11. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
Miletic VD; Hester CG; Frank MM
J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
[TBL] [Abstract][Full Text] [Related]
12. The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation.
Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
Mol Immunol; 1988 Dec; 25(12):1355-61. PubMed ID: 3266294
[TBL] [Abstract][Full Text] [Related]
13. The effects of immunoglobulin isotype and antibody affinity on complement-mediated inhibition of immune precipitation and solubilization.
Johnson A; Harkin S; Steward MW; Whaley K
Mol Immunol; 1987 Nov; 24(11):1211-7. PubMed ID: 3696168
[TBL] [Abstract][Full Text] [Related]
14. The influence of antibody functional affinity on the effector functions involved in the clearance of circulating immune complexes anti-BSA IgG/BSA.
Marzocchi-Machado CM; Polizello AC; Azzolini AE; Lucisano-Valim YM
Immunol Invest; 1999; 28(2-3):89-101. PubMed ID: 10484684
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin-mediated shifting of immune complexes to increased complement-dependent solubility and immunoadherence.
Spycher MO; Späth PJ; Häsig A; Nydegger UE
Mol Immunol; 1984 Jun; 21(6):497-505. PubMed ID: 6431266
[TBL] [Abstract][Full Text] [Related]
16. The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation.
Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
Mol Immunol; 1990 May; 27(5):423-8. PubMed ID: 2366759
[TBL] [Abstract][Full Text] [Related]
17. Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein.
Giuntini S; Reason DC; Granoff DM
Infect Immun; 2012 Jan; 80(1):187-94. PubMed ID: 22064712
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.
Emlen W; Carl V; Burdick G
Clin Exp Immunol; 1992 Jul; 89(1):8-17. PubMed ID: 1385769
[TBL] [Abstract][Full Text] [Related]
19. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
20. OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.
Saad AF; Virella G; Chassereau C; Boackle RJ; Lopes-Virella MF
J Lipid Res; 2006 Sep; 47(9):1975-83. PubMed ID: 16804192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
